Do implantable cardioverter-defibrillators prevent sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy?
A single marker of high risk for sudden death may be sufficient to justify prophylactic ICD implantation in selected patients with hypertrophic cardiomyopathy.
In a high-risk HCM cohort, ICD interventions for life-threatening ventricular tachyarrhythmias were frequent and highly effective in restoring normal rhythm. An important proportion of ICD discharges occurred in primary prevention patients who had undergone implantation for a single risk factor. Therefore, a single marker of high risk for sudden death may be sufficient to justify consideration for prophylactic defibrillator implantation in selected patients with HCM.
Maron et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: